Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and hmr 1098

2-chloro-n(6)cyclopentyladenosine has been researched along with hmr 1098 in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(hmr 1098)
Trials
(hmr 1098)
Recent Studies (post-2010) (hmr 1098)
2520435805

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fox, JE; French, RJ; Kanji, HD; Light, PE1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and hmr 1098

ArticleYear
Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:14

    Topics: Adenosine; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Calcium; Cell Hypoxia; Cell Line; Cell Survival; Cells, Cultured; Decanoic Acids; Dose-Response Relationship, Drug; Enzyme Activation; Heart Ventricles; Humans; Hydroxy Acids; Ischemic Preconditioning, Myocardial; KATP Channels; Luminescent Proteins; Membrane Potentials; Mitochondria; Myocardium; Oxygen; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Recombinant Fusion Proteins; Sarcolemma; Time Factors; Ventricular Function; Xanthines

2001